BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This specialized material comprises 5-fluorouracil magnetic nanoliposomes (MNLF) designed with an inorganic-organic hybrid core-shell architecture. The internal structure encapsulates the hydrophilic antimetabolite drug 5-fluorouracil along with superparamagnetic iron oxide nanoparticles within the central aqueous core and interfacial domains of a robust phospholipid vesicle matrix. This configuration coordinates the magnetic nanoparticles near the polar headgroups of the lipid bilayer, introducing a strong response to external magnetic fields while restricting the passive leakage of the water-soluble drug across the membrane interface. The resulting magnetic nanoliposomes exhibit a narrow sub-micron size distribution and high colloidal stability.
Source
Custom synthesis
Functional Group
5-Fluorouracil; Magnetic component
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.